{"bill": {"@star-print": "no-star-print", "#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "@display": "no", "#text": "IN THE SENATE OF THE UNITED\n\t\t  STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "@display": "yes", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "@display": "yes", "#text": "S. 622"}, "official-title": {"#tail": "\n\t", "@display": "yes", "#text": "To amend the Federal Food, Drug, and\n\t\t  Cosmetic Act to reauthorize user fee programs relating to new animal drugs and\n\t\t  generic new animal drugs."}, "@display": "yes", "session": {"#tail": "\n\t\t", "@display": "yes", "#text": "1st Session"}, "legis-type": {"#tail": "\n\t\t", "@display": "yes", "#text": "AN ACT"}}, "attestation": {"#tail": "\n\t", "attestation-group": {"#tail": "\n\t", "role": {"#tail": "\n\t\t", "#text": "Secretary"}, "#text": "\n\t\t\t", "attestor": {"#tail": "\n\t\t\t", "@display": "no"}, "attestation-date": {"#tail": "\n\t\t\t", "@date": "20130508", "#text": "Passed the Senate\n\t\t\t May 8, 2013.", "@chamber": "Senate"}}, "#text": "\n\t\t"}, "@stage-count": "1", "@bill-stage": "Engrossed-in-Senate", "@bill-type": "olc", "endorsement": {"#tail": "\n", "@display": "yes", "#text": "\n\t"}, "@public-private": "public", "legis-body": {"@style": "OLC", "title": [{"@level-type": "subsequent", "section": [{"@section-type": "subsequent-section", "#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "101."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Short title; finding", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "#text": "Animal Drug User Fee Amendments of 2013"}, "#text": "This title may be cited as the\n\t\t\t ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Short title", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id4D67D4B50BC5474399DBCD21987163B9", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in the letters from the ", "@entity-type": "act", "#text": "part 4 of subchapter C of chapter VII of\n\t\t\t the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, {"#tail": " to the ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Chairman of the Committee on Energy and\n\t\t\t Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " as set forth in the\n\t\t\t Congressional Record.", "@entity-type": "committee", "#text": "Chairman of the Committee on\n\t\t\t Health, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "Congress finds that the fees authorized by\n\t\t\t the amendments made in this title will be dedicated toward expediting the\n\t\t\t animal drug development process and the review of new and supplemental animal\n\t\t\t drug applications and investigational animal drug submissions as set forth in\n\t\t\t the goals identified, for purposes of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Finding", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "idCCB5BB80E2324FCCBA82464242AA3C39", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idF24B38947FC6403FAF022C0E445C8BB9", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 739 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:739"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/379j-11", "#text": "21 U.S.C. 379j\u201311", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "102."}, "header": {"#tail": "\n        ", "#text": "Definitions", "@display-inline": "yes-display-inline"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"@section-type": "subsequent-section", "#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "For purposes of this part:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n            ", "#text": "739."}, "header": {"#tail": "\n            ", "#text": "Definitions", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ". Such term does not include\n\t\t\t\teither a new animal drug application submitted under ", "@entity-type": "act", "#text": "section 512(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:1"}, {"#tail": " or a\n\t\t\t\tsupplemental animal drug application.", "@entity-type": "act", "#text": "section 512(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:2"}], "term": {"#tail": " means an application for approval of any\n\t\t\t\tnew animal drug submitted under ", "#text": "animal drug application"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id2baecaa2201646fd847452d9d7af16b4", "@commented": "no"}, {"@id": "id75dc24faa3c34c498fbfd7528f195f29", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "supplemental animal drug\n\t\t\t\tapplication"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to approve a change in an animal drug application which has been\n\t\t\t\tapproved; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "a request to the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id8d119fd21c4648d1a326ef814ae2b4b4", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to approve a change to an application approved under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for which data with respect to safety or effectiveness are\n\t\t\t\trequired.", "@entity-type": "act", "#text": "section\n\t\t\t\t512(c)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:c/p:2"}], "#text": "a request to the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id51e3012b17c1410a992ed6c288462421", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans each specific strength or potency of a particular active ingredient or\n\t\t\t\tingredients in final dosage form marketed by a particular manufacturer or\n\t\t\t\tdistributor, which is uniquely identified by the labeler code and product code\n\t\t\t\tportions of the national drug code, and for which an animal drug application or\n\t\t\t\ta supplemental animal drug application has been approved.", "#text": "animal drug product"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id6a97e76f119640d7b7489daab6a5cb06", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a foreign or domestic place of business which is at\n\t\t\t\tone general physical location consisting of one or more buildings all of which\n\t\t\t\tare within 5 miles of each other, at which one or more animal drug products are\n\t\t\t\tmanufactured in final dosage form.", "#text": "animal drug\n\t\t\t\testablishment"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id45066d48e5bb4af196d4277a5d52bba1", "@commented": "no"}, {"@id": "ide9601ceef80e4db78d44d5541181cf2b", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "investigational animal drug\n\t\t\t\tsubmission"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a new animal\n\t\t\t\tdrug intended to be the subject of an animal drug application or a supplemental\n\t\t\t\tanimal drug application; or", "@entity-type": "act", "#text": "section 512(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:j"}, "#text": "the filing of a\n\t\t\t\tclaim for an investigational exemption under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id2edccab7936b46849d1ecbf6ec00a0d1", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to evaluate the safety or\n\t\t\t\teffectiveness of an animal drug application or supplemental animal drug\n\t\t\t\tapplication in the event of their filing.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the submission of\n\t\t\t\tinformation for the purpose of enabling the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id2752196ae8cb42f28d7d3fb12d4b4533", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or a person who has submitted\n\t\t\t\tan investigational animal drug submission that has not been terminated or\n\t\t\t\totherwise rendered inactive by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means either an applicant named in an animal\n\t\t\t\tdrug application that has not been withdrawn by the applicant and for which\n\t\t\t\tapproval has not been withdrawn by the ", "#text": "animal drug sponsor"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idab5aa508c9ec4de8ac04cf107a60fd1b", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans, with respect to an animal drug product, a finished dosage form which is\n\t\t\t\tapproved for administration to an animal without substantial further\n\t\t\t\tmanufacturing. Such term includes animal drug products intended for mixing in\n\t\t\t\tanimal feeds.", "#text": "final dosage form"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id59ce977dfbc243cab1f36852f9980932", "@commented": "no"}, {"@id": "id8d7966ae48ef4a6fb99cb5bdb30638fd", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to the review of animal drug\n\t\t\t\tapplications, supplemental animal drug applications, and investigational animal\n\t\t\t\tdrug submissions:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means the\n\t\t\t\tfollowing activities of the ", "#text": "process for the review of animal drug applications"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(8)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The activities necessary for the review of\n\t\t\t\tanimal drug applications, supplemental animal drug applications, and\n\t\t\t\tinvestigational animal drug submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id57760b3930c54f8b9873957f96fb72cb", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The issuance of action letters which\n\t\t\t\tapprove animal drug applications or supplemental animal drug applications or\n\t\t\t\twhich set forth in detail the specific deficiencies in animal drug\n\t\t\t\tapplications, supplemental animal drug applications, or investigational animal\n\t\t\t\tdrug submissions and, where appropriate, the actions necessary to place such\n\t\t\t\tapplications, supplements or submissions in condition for approval.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id0e6dbab31cf54fd2a5ed64fd3059f60b", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " review of pending animal drug applications, supplemental animal\n\t\t\t\tdrug applications, and investigational animal drug submissions.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}, "#text": "The inspection of\n\t\t\t\tanimal drug establishments and other facilities undertaken as part of the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "ida5ed9b515c064d799b9b1dd5bd635681", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Monitoring of research conducted in\n\t\t\t\tconnection with the review of animal drug applications, supplemental animal\n\t\t\t\tdrug applications, and investigational animal drug submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id4660e2af831f46c6b5219d1b9b5088a3", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The development of regulations and policy\n\t\t\t\trelated to the review of animal drug applications, supplemental animal drug\n\t\t\t\tapplications, and investigational animal drug submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id16c5e7d415c240c39e1a7764e7c8aa43", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Development of standards for products\n\t\t\t\tsubject to review.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idbca0bdd8d87d4c42987b6660266a124a", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Meetings between the agency and the animal\n\t\t\t\tdrug sponsor.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idd31eb8de324c4ed98b7d171b426aa0d6", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Review of advertising and labeling prior to\n\t\t\t\tapproval of an animal drug application or supplemental animal drug application,\n\t\t\t\tbut not after such application has been approved.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id9ec33da95791400882f4a37b4d293a0d", "@commented": "no"}], "@commented": "no"}, {"@id": "id280ae9c17847498cb26aebb44e12376e", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the\n\t\t\t\texpenses in connection with the process for the review of animal drug\n\t\t\t\tapplications for\u2014", "#text": "costs of resources allocated\n\t\t\t\tfor the process for the review of animal drug applications"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(9)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", contractors of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", advisory committees consulted with respect to the review of\n\t\t\t\tspecific animal drug applications, supplemental animal drug applications, or\n\t\t\t\tinvestigational animal drug submissions, and costs related to such officers,\n\t\t\t\temployees, committees, and contractors, including costs for travel, education,\n\t\t\t\tand recruitment and other personnel activities;", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "officers and\n\t\t\t\temployees of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id4a075b710b6a4c508c6b1e88e547b378", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "management of information and the\n\t\t\t\tacquisition, maintenance, and repair of computer resources;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idb8bac221e506493fa513ba7b1b6488cc", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "leasing, maintenance, renovation, and\n\t\t\t\trepair of facilities and acquisition, maintenance, and repair of fixtures,\n\t\t\t\tfurniture, scientific equipment, and other necessary materials and supplies;\n\t\t\t\tand", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id0f945ec9caf748b3a1398c0ece5557e3", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and accounting for resources allocated for the review of\n\t\t\t\tanimal drug applications, supplemental animal drug applications, and\n\t\t\t\tinvestigational animal drug submissions.", "@entity-type": "act", "#text": "section 740", "@value": "Federal Food, Drug, and Cosmetic Act/s:740"}, "#text": "collecting fees\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id33d0d930d7814ff1ab1fa64b560de746", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with the base or comparator month being\n\t\t\t\tOctober 2002.", "@entity-type": "act", "#text": "section 735(8)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:8"}, "term": {"#tail": " applicable to a fiscal year refers to the\n\t\t\t\tformula set forth in ", "#text": "adjustment factor"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(10)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idda64e305fd5e4f5ba8c1921029ec65db", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " includes an\n\t\t\t\taffiliate thereof.", "#text": "person"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(11)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idd530b8631d82409d9e199b02bf4b90b9", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " refers to the definition set forth in ", "#text": "affiliate"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(12)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "ida520e53d480c419d99108ffc83029fe8", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id2cfb2137b4f849b28383ff7535ad2157", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id2B676713CF5A43E7A28E98883B5193AF"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id18C46899033642ECAD36671387E81948", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 740 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/379j-12", "#text": "21 U.S.C. 379j\u201312", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "103."}, "header": {"#tail": "\n        ", "#text": "Authority to assess and use animal drug\n\t\t\t fees", "@display-inline": "yes-display-inline"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"@section-type": "subsequent-section", "#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "740."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Authority to assess and use animal drug\n\t\t\t\tfees", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall assess\n\t\t\t\tand collect fees in accordance with this section as follows:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning in fiscal year 2004, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Types of fees", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "@id": "id856c6a5f331349858672440b4b1afaef", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug application and supplement\n\t\t\t\tfee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person that submits, on or after\n\t\t\t\tSeptember 1, 2003, an animal drug application or a supplemental animal drug\n\t\t\t\tapplication shall be subject to a fee as follows:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for an\n\t\t\t\tanimal drug application, except an animal drug application subject to the\n\t\t\t\tcriteria set forth in ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}], "#text": "A fee established in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idf3be932ff6c44f0eb559e8781c278625", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in an amount that is equal to 50 percent of\n\t\t\t\tthe amount of the fee under ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ", for\u2014", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A/cl:i", "@proposed": "true"}], "#text": "A\n\t\t\t\tfee established in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a supplemental animal drug application for\n\t\t\t\twhich safety or effectiveness data are required; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "no-display-inline", "#text": "\n                      ", "@id": "id71eba9cd8cc9432bb086eae9b19271f1", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}, "#text": "an animal drug application subject to the\n\t\t\t\tcriteria set forth in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@display-inline": "no-display-inline", "#text": "\n                      ", "@id": "iddaa6e8cc556745eba9d35e6e6cfdf566", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id0ea29b3247bb47aebd6f6599a5adb1f7", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id96eff9f07a5842a4a4b1a8d0e987e7f7", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be due upon submission of the animal\n\t\t\t\tdrug application or supplemental animal drug application.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tfee required by ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idad0ccb7a9ce2485e856a3962aa83a00b", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "If an animal drug\n\t\t\t\tapplication or a supplemental animal drug application was submitted by a person\n\t\t\t\tthat paid the fee for such application or supplement, was accepted for filing,\n\t\t\t\tand was not approved or was withdrawn (without a waiver or refund), the\n\t\t\t\tsubmission of an animal drug application or a supplemental animal drug\n\t\t\t\tapplication for the same product by the same person (or the person\u2019s licensee,\n\t\t\t\tassignee, or successor) shall not be subject to a fee under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Exception for previously filed application\n\t\t\t\tor supplement", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id00381df24dbb4c6fa9672051607e83ff", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall refund 75\n\t\t\t\tpercent of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for any animal drug application\n\t\t\t\tor supplemental animal drug application which is refused for filing.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if application refused for\n\t\t\t\tfiling", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id1fb0e71de8754f73b85f71fbdeec1d3a", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may refund the fee or portion of the fee\n\t\t\t\tpaid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if no substantial work was performed on the\n\t\t\t\tapplication or supplement after the application or supplement was filed. The\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": " shall have the sole discretion to refund the fee under this\n\t\t\t\tparagraph. A determination by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " concerning a refund under this\n\t\t\t\tparagraph shall not be reviewable.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an animal drug application or a\n\t\t\t\tsupplemental animal drug application is withdrawn after the application or\n\t\t\t\tsupplement was filed, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if application\n\t\t\t\twithdrawn", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ida24a0748809b462995e81936d8d6a70c", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "@id": "idd244aeb1ac2344d6963dbdab2111e2ec", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug product fee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall pay for each such animal\n\t\t\t\tdrug product the annual fee established in ", "@commented": "no"}, "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who is named as the applicant in an animal\n\t\t\t\tdrug application or supplemental animal drug application for an animal drug\n\t\t\t\tproduct which has been submitted for listing under section 510; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idBC3298020FB0493AA055F3DCBFD9368F", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who, after September 1, 2003, had pending\n\t\t\t\tbefore the Secretary an animal drug application or supplemental animal drug\n\t\t\t\tapplication,", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id05148E5A0284418DA64B1C1692C81E56", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ida938326684b7416ab2de970e84282893", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or is\n\t\t\t\tsubmitted for relisting under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the animal drug product has been\n\t\t\t\twithdrawn from listing and relisted. After such fee is paid for that fiscal\n\t\t\t\tyear, such fee shall be due each subsequent fiscal year that the product\n\t\t\t\tremains listed, upon the later of\u2014", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "Such fee shall be payable for the fiscal year in which the\n\t\t\t\tanimal drug product is first submitted for listing under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day after the date of\n\t\t\t\tenactment of an appropriations Act providing for the collection and obligation\n\t\t\t\tof fees for such fiscal year under this section; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id2a6ea392d4da47048129573d63242b2b", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idb2ec0ea5d79140838a1d2f511c1e3dc7", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Payment; fee due date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id286d4e36fdf44cd9bc435819a7fbd697", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such fee shall be paid only once for each\n\t\t\t\tanimal drug product for a fiscal year in which the fee is payable.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id2c4425400aea4a6b88a4e752b3c37385", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "@id": "idec70ef13a7d74d6ba337a08e294490a4", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug establishment fee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for each animal drug\n\t\t\t\testablishment listed in its approved animal drug application as an\n\t\t\t\testablishment that manufactures the animal drug product named in the\n\t\t\t\tapplication.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall be assessed an annual\n\t\t\t\testablishment fee as established in ", "@commented": "no"}, "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who owns or operates, directly or through\n\t\t\t\tan affiliate, an animal drug establishment;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id4acd4cf9864a448a847fa0d313f4f3a3", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as the applicant in an animal\n\t\t\t\tdrug application or supplemental animal drug application for an animal drug\n\t\t\t\tproduct which has been submitted for listing under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id642d0b026cdc4f2bbe966b32014f852e", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application or supplemental animal drug\n\t\t\t\tapplication,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after September 1, 2003, had pending\n\t\t\t\tbefore the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id9c7fb6e0216b4ece94ac63dfe6413f60", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id010c49a9657a4137bd22196c97c59427", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " unless the animal drug establishment listed\n\t\t\t\tin the application does not engage in the manufacture of the animal drug\n\t\t\t\tproduct during the fiscal year. The fee under this paragraph for a fiscal year\n\t\t\t\tshall be due upon the later of\u2014", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:2", "@proposed": "true"}, "#text": "The annual establishment fee shall be assessed in each\n\t\t\t\tfiscal year in which the animal drug product named in the application is\n\t\t\t\tassessed a fee under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day after the date of\n\t\t\t\tenactment of an appropriations Act providing for the collection and obligation\n\t\t\t\tof fees for such fiscal year under this section; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id6c8e2638580f4fecab2326fb11e275e1", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id8288061bb7b24630b96cd9f96dad6f2e", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Payment; fee due date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id3f9baeb57de64faf8d8657f94716b49e", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:3/sp:C/cl:ii", "@proposed": "true"}, "#text": "An establishment shall be assessed only one fee per\n\t\t\t\tfiscal year under this section, subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id85654F3F1AD54EE7BCE665138E7EBF7A", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\tsuch establishment shall be assessed both the animal drug establishment fee and\n\t\t\t\tthe prescription drug establishment fee, as set forth in ", "@entity-type": "act", "#text": "section 735(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:3"}, {"#tail": ",\n\t\t\t\twithin a single fiscal year.", "@entity-type": "act", "#text": "section 736(a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:736/ss:a/p:2"}], "#text": "If a single establishment manufactures both animal\n\t\t\t\tdrug products and prescription drug products, as defined in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Certain manufacturers", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id4C9A24E9FF104B879A9F8E585E05E10A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Limitation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id1ca0cb6f97034855983c73b83030b397", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "@id": "id5e99b2cdcba34a879d151c9d44a84bb1", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug sponsor fee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall be assessed an annual\n\t\t\t\tsponsor fee as established under ", "@commented": "no"}, "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who meets the definition of an animal drug\n\t\t\t\tsponsor within a fiscal year; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id4713777554EA4736B68AE28C4A83A989", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application,\n\t\t\t\ta supplemental animal drug application, or an investigational animal drug\n\t\t\t\tsubmission,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2003, had pending before the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id75DDE84866DB44BCA26229F56E7666E2", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idc86ef39ce2f34dd3a7ce643d12eba1a6", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fee under this paragraph for a fiscal\n\t\t\t\tyear shall be due upon the later of\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day after the date of\n\t\t\t\tenactment of an appropriations Act providing for the collection and obligation\n\t\t\t\tof fees for such fiscal year under this section; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id7e4068f8a77841669b9f09685ef74e6e", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "iddb992fd0b12f410fb9360a188d36568c", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Payment; fee due date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id9bbd59ab18014db9917df43009811793", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Each animal drug sponsor shall pay only one\n\t\t\t\tsuch fee each fiscal year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idf247453a92744a588729e8746796c011", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id2dc2344c349f4586842f585b9e903b2a", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fee revenue amounts", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:f", "@proposed": "true"}, {"#tail": "\u2014", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g", "@proposed": "true"}], "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idc6f6d9a0f4fb4101bf6de214b0d82488", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be established to generate a\n\t\t\t\ttotal revenue amount of $23,600,000; and", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, "#text": "for fiscal year\n\t\t\t\t2014, the fees required under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id6a536a7f69564371933dc08c908acabf", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\testablished to generate a total revenue amount of $21,600,000.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, "#text": "for each of fiscal\n\t\t\t\tyears 2015 through 2018, the fees required under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idb13cfed06f6e4e7aa99336a2bf060685", "@commented": "no"}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b/p:1", "@proposed": "true"}, "#text": "Of the total revenue amount determined for a fiscal year\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Types of fees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idee0a35c16b3a4f43ad07525becf7368b", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tapplications and supplements);", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1", "@proposed": "true"}, "#text": "20 percent shall\n\t\t\t\tbe derived from fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idcba4797710da4bcf9dac068921f3f593", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tproducts);", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:2", "@proposed": "true"}, "#text": "27 percent shall\n\t\t\t\tbe derived from fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ide8c86e8cc8f744a99e582ad1290ed7eb", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\testablishments); and", "@entity-type": "act", "#text": "subsection (a)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:3", "@proposed": "true"}, "#text": "26 percent shall\n\t\t\t\tbe derived from fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id85513e950b0c458eb546e8af614947ef", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tsponsors).", "@entity-type": "act", "#text": "subsection (a)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:4", "@proposed": "true"}, "#text": "27 percent shall\n\t\t\t\tbe derived from fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id3cd66be54caf46099e22401bebd73de5", "@commented": "no"}]}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idaf35bbefbdb747f09941f1977c0d1bdc", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Annual fee setting; adjustments", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, 60 days before the start\n\t\t\t\tof each fiscal year beginning after September 30, 2003, for that fiscal year,\n\t\t\t\tanimal drug application fees, supplemental animal drug application fees, animal\n\t\t\t\tdrug sponsor fees, animal drug establishment fees, and animal drug product fees\n\t\t\t\tbased on the revenue amounts established under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the\n\t\t\t\tadjustments provided under this subsection.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Annual fee setting", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id1be44308ec41422c91c09183f6d5a32f", "@commented": "no"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "paragraph", "#text": "The adjustment made each fiscal year\n\t\t\t\tunder this paragraph shall be added on a compounded basis to the sum of all\n\t\t\t\tadjustments made each fiscal year after fiscal year 2014 under this\n\t\t\t\tparagraph.", "@commented": "no"}, "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be adjusted by the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": " by notice, published in the Federal Register, for a fiscal year, by\n\t\t\t\tan amount equal to the sum of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years, the\n\t\t\t\trevenue amounts established in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Inflation adjustment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idab2a98ea0a174a14b3c19e52ec354a1f", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "one;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id11ecb2d82c084e5b85946436249a2b58", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid with\n\t\t\t\trespect to such positions for the first 3 of the preceding 4 fiscal years for\n\t\t\t\twhich data are available, multiplied by the average proportion of personnel\n\t\t\t\tcompensation and benefits costs to total ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}, {"#tail": " costs for\n\t\t\t\tthe first 3 years of the preceding 4 fiscal years for which data are available;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "the average annual\n\t\t\t\tpercent change in the cost, per full-time equivalent position of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id45520518539845659230174a4d7e3886", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tcosts for the first 3 years of the preceding 4 fiscal years for which data are\n\t\t\t\tavailable.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "the average annual percent change that\n\t\t\t\toccurred in the Consumer Price Index for urban consumers (Washington-Baltimore,\n\t\t\t\tDC\u2013MD\u2013VA\u2013WV; not seasonally adjusted; all items less food and energy; annual\n\t\t\t\tindex) for the first 3 years of the preceding 4 years for which data are\n\t\t\t\tavailable multiplied by the average proportion of all costs other than\n\t\t\t\tpersonnel compensation and benefits costs to total ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ide1111c4d711a4bc0b60c7bdf4ef39252", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " are adjusted for\n\t\t\t\tinflation in accordance with ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": ", the revenue amounts shall be\n\t\t\t\tfurther adjusted for such fiscal year to reflect changes in the workload of the\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c/p:2", "@proposed": "true"}, {"#tail": " for the process for the review of animal drug applications. With\n\t\t\t\trespect to such adjustment\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years,\n\t\t\t\tafter the revenue amounts established in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Workload adjustment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "ida926d9804abd48fa97bb5eafb148e7d3", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based on a weighted average of the change\n\t\t\t\tin the total number of animal drug applications, supplemental animal drug\n\t\t\t\tapplications for which data with respect to safety or effectiveness are\n\t\t\t\trequired, manufacturing supplemental animal drug applications, investigational\n\t\t\t\tanimal drug study submissions, and investigational animal drug protocol\n\t\t\t\tsubmissions submitted to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "such adjustment\n\t\t\t\tshall be determined by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id8cf934fc86e7475cb281bedfcfde33c6", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall publish in the Federal Register the fees resulting from such adjustment\n\t\t\t\tand the supporting methodologies; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idA23B3BFEEFD947EDB19E5DF7AE6AB4DF", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as adjusted for inflation under ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c/p:2", "@proposed": "true"}], "#text": "under no\n\t\t\t\tcircumstances shall such adjustment result in fee revenues for a fiscal year\n\t\t\t\tthat are less than the fee revenues for that fiscal year established in\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id241d33caa9aa4458a1ffefc8dde96f73", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in\n\t\t\t\taddition to other adjustments under this subsection, further increase the fees\n\t\t\t\tunder this section, if such an adjustment is necessary, to provide for up to 3\n\t\t\t\tmonths of operating reserves of carryover user fees for the process for the\n\t\t\t\treview of animal drug applications for the first 3 months of fiscal year 2019.\n\t\t\t\tIf the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has carryover balances for the process for\n\t\t\t\tthe review of animal drug applications in excess of 3 months of such operating\n\t\t\t\treserves, then this adjustment will not be made. If this adjustment is\n\t\t\t\tnecessary, then the rationale for the amount of the increase shall be contained\n\t\t\t\tin the annual notice setting fees for fiscal year 2018.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "For fiscal year 2018, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Final year adjustment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id22d236418f804be3a2a7dec79c87d001", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The total amount of fees charged, as\n\t\t\t\tadjusted under this subsection, for a fiscal year may not exceed the total\n\t\t\t\tcosts for such fiscal year for the resources allocated for the process for the\n\t\t\t\treview of animal drug applications.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Limit", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id41001dd940b1473fb08295986f21c6a6", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id1a1c4f8297ca4fa5adf7d7ad041d4c12", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fee waiver or reduction", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant a waiver from or a reduction of\n\t\t\t\tone or more fees assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " finds\n\t\t\t\tthat\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idaca03700b2a3458da373e43ed7ee6165", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the assessment of the fee would present a\n\t\t\t\tsignificant barrier to innovation because of limited resources available to\n\t\t\t\tsuch person or other circumstances;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id0605974517334d95abb436828ad5217f", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in conducting the process for the review of animal\n\t\t\t\tdrug applications for such person;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the fees to be\n\t\t\t\tpaid by such person will exceed the anticipated present and future costs\n\t\t\t\tincurred by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id748e3a4b940b4602a7fed665a4d4d2f9", "@commented": "no"}, {"@display-inline": "no-display-inline", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the animal drug application or supplemental\n\t\t\t\tanimal drug application is intended solely to provide for use of the animal\n\t\t\t\tdrug in\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a Type B medicated feed (as defined in\n\t\t\t\t", "external-xref": {"#tail": " of title 21, Code of Federal Regulations (or any successor\n\t\t\t\tregulation)) intended for use in the manufacture of Type C free-choice\n\t\t\t\tmedicated feeds; or", "@parsable-cite": "cfr/21/558.3", "#text": "section 558.3(b)(3)", "@legal-doc": "regulation"}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "ide819f3de5b8445eebfd87cb6df3ffdfb", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a Type C free-choice medicated feed (as\n\t\t\t\tdefined in ", "external-xref": {"#tail": " of title 21, Code of Federal Regulations (or any\n\t\t\t\tsuccessor regulation));", "@parsable-cite": "cfr/21/558.3", "#text": "section 558.3(b)(4)", "@legal-doc": "regulation"}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "ida97a890bfb924c4f97282e53e50429be", "@commented": "no"}], "#text": "\n                  ", "@id": "id0888a19d88004833bc3af69869fd5f22", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the animal drug application or supplemental\n\t\t\t\tanimal drug application is intended solely to provide for a minor use or minor\n\t\t\t\tspecies indication; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id54867149a9004d5fa36e326209f80ad0", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for review.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the sponsor\n\t\t\t\tinvolved is a small business submitting its first animal drug application to\n\t\t\t\tthe ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id27ee5fb886bf42fdb513d26ac1754466", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:B", "@proposed": "true"}, {"#tail": "\n\t\t\t\tmay use standard costs.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In making the finding in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Use of standard costs", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idf1216e118c0a48c2941625019319b283", "@commented": "no"}, {"#tail": "\n            ", "@id": "idac78667703e048a2a2b309c08878a132", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Rules for small businesses", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term ", "@entity-type": "act", "#text": "paragraph (1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, "term": {"#tail": " means an entity that has\n\t\t\t\tfewer than 500 employees, including employees of affiliates.", "#text": "small business"}, "#text": "In\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Definition", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id63490f3311f24674a2a20d163fa01089", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall waive under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tthe application fee for the first animal drug application that a small business\n\t\t\t\tor its affiliate submits to the ", "@entity-type": "act", "#text": "paragraph (1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": " for review. After a small business or\n\t\t\t\tits affiliate is granted such a waiver, the small business or its affiliate\n\t\t\t\tshall pay application fees for all subsequent animal drug applications and\n\t\t\t\tsupplemental animal drug applications for which safety or effectiveness data\n\t\t\t\tare required in the same manner as an entity that does not qualify as a small\n\t\t\t\tbusiness.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Waiver of application fee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id8389047c675f4977af7588406623de9b", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require any person who applies for a waiver under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to certify their qualification for the waiver. The ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": " shall\n\t\t\t\tperiodically publish in the Federal Register a list of persons making such\n\t\t\t\tcertifications.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Certification", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ide87ea137ffb94c83ba6358425b8ae68b", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id5f5654bf3e724bb5ad446f03903c5dad", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered incomplete and shall not be accepted for filing by the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person have been paid. An investigational\n\t\t\t\tanimal drug submission under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that is submitted by a person\n\t\t\t\tsubject to fees under ", "@entity-type": "act", "#text": "section 739(5)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:739/p:5/sp:B", "@proposed": "true"}, {"#tail": " shall be considered incomplete and shall\n\t\t\t\tnot be accepted for review by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person\n\t\t\t\thave been paid. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may discontinue review of any animal drug\n\t\t\t\tapplication, supplemental animal drug application or investigational animal\n\t\t\t\tdrug submission from a person if such person has not submitted for payment all\n\t\t\t\tfees owed under this section by 30 days after the date upon which they are\n\t\t\t\tdue.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An animal drug application or supplemental\n\t\t\t\tanimal drug application submitted by a person subject to fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Effect of failure To pay fees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "ide7cd2c8d294d4fc3ae7c308c5a04b6f2", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment of fees", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year beginning after\n\t\t\t\tfiscal year 2003 unless appropriations for salaries and expenses of the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " for such fiscal year (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) are equal to or greater than the amount of\n\t\t\t\tappropriations for the salaries and expenses of the ", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, {"#tail": " for the fiscal year 2003 (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) multiplied by the adjustment factor\n\t\t\t\tapplicable to the fiscal year involved.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "Fees\n\t\t\t\tmay not be assessed under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id8097173620504c51b2377b93e98f8166", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not assess fees under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " during any portion of a fiscal year because of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " and\n\t\t\t\tif at a later date in such fiscal year the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:f/p:1", "@proposed": "true"}, {"#tail": " may assess such fees, the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect such fees, without any modification in the\n\t\t\t\trate, for animal drug applications, supplemental animal drug applications,\n\t\t\t\tinvestigational animal drug submissions, animal drug sponsors, animal drug\n\t\t\t\testablishments and animal drug products at any time in such fiscal year\n\t\t\t\tnotwithstanding the provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " relating to the date fees are\n\t\t\t\tto be paid.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}], "#text": "If the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Authority", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "ide7984a1f0bf44d048c6f6fc03396fa82", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id65edffaa16784560a40ead49845e81e5", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Crediting and availability of fees", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", fees authorized under\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:C", "@proposed": "true"}, {"#tail": " shall be collected and available for obligation only to the\n\t\t\t\textent and in the amount provided in advance in appropriations Acts. Such fees\n\t\t\t\tare authorized to be appropriated to remain available until expended. Such sums\n\t\t\t\tas may be necessary may be transferred from the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tsalaries and expenses appropriation account without fiscal year limitation to\n\t\t\t\tsuch appropriation account for salary and expenses with such fiscal year\n\t\t\t\tlimitation. The sums transferred shall be available solely for the process for\n\t\t\t\tthe review of animal drug applications.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id69eefe8b0407495781fe5652401c79d4", "@commented": "no"}, {"#tail": "\n              ", "@id": "id9f693160d00841d9812c3b60ddd7ac5f", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collections and appropriation acts", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fees authorized by this section\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall be\n\t\t\t\tcollected and available in each fiscal year in an amount not to exceed the\n\t\t\t\tamount specified in appropriation Acts, or otherwise made available for\n\t\t\t\tobligation for such fiscal year, and", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:C", "@proposed": "true"}, "#text": "subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id06bada831ef44b2b83d2b209e2b20282", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be engaged in such process) over\n\t\t\t\tsuch costs, excluding costs paid from fees collected under this section, for\n\t\t\t\tfiscal year 2003 multiplied by the adjustment factor.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "shall be\n\t\t\t\tavailable to defray increases in the costs of the resources allocated for the\n\t\t\t\tprocess for the review of animal drug applications (including increases in such\n\t\t\t\tcosts for an additional number of full-time equivalent positions in the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id46588b6b48e84a3f83c15e128c4fd3b2", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id1e7f16bd4e9244d19b3f9d9a1b05c393", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered to have met the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in any fiscal year if the costs funded by appropriations and allocated\n\t\t\t\tfor the process for the review of animal drug applications\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:720/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:720/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "are not more than 3 percent below the level\n\t\t\t\tspecified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id403d638ecdd940a8b4b5df219a49f2c2", "@commented": "no"}, {"#tail": "\n                ", "@id": "id5d49f7d3dd7949dabc7af64aa5601d38", "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and fees assessed for the fiscal year\n\t\t\t\tfollowing the subsequent fiscal year are decreased by the amount in excess of 3\n\t\t\t\tpercent by which such costs fell below the level specified in ", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:720/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:720/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "are more than 3 percent below the level\n\t\t\t\tspecified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id843D35BAAB274BAFB62E986A7096C7C2", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:720/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "such costs are not more than 5 percent\n\t\t\t\tbelow the level specified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@display-inline": "no-display-inline", "#text": "\n                      ", "@id": "idB5FA6A04D5DF454B997DB044F9DFCE62", "@commented": "no"}], "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Compliance", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id392449b0361a4c37b7b53aad1ef92fcb", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in accordance with authority provided in advance in a prior\n\t\t\t\tyear appropriations Act.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Payment of fees authorized under this\n\t\t\t\tsection for a fiscal year, prior to the due date for such fees, may be accepted\n\t\t\t\tby the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Provision for early payments", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id31dff28713af4d34bad74c8d4bee74b4", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4", "@proposed": "true"}], "{http://namespaces.cato.org/catoxml}property": {"#tail": " an amount\n\t\t\t\tequal to the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "this section", "@value": "Federal Food, Drug, and Cosmetic Act/s:740", "@proposed": "true"}, "#text": "for fees under ", "@name": "purpose"}, "#tail": "\n                ", "@entity-type": "auth-auth-approp", "{http://namespaces.cato.org/catoxml}funds-and-year": [{"#tail": " ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, "@amount": "23600000", "#text": "total revenue amount determined under ", "@year": "2014"}, {"#tail": ", as adjusted or otherwise affected under ", "#text": "for the\n\t\t\t\tfiscal year", "@amount": "21600000", "@year": "2015, 2016, 2017, 2018"}], "#text": "For each of the fiscal years 2014 through 2018,\n\t\t\t\tthere is authorized to be appropriated "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorization of\n\t\t\t\tappropriations", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id9edc07c1ec99401386901a6f38345481", "@commented": "no"}, {"#tail": "\n            ", "@id": "idccfd5c44eb3448a68c4d6e6b4c9dd806", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Offset of overcollections; recovery of\n\t\t\t\tcollection shortfalls", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "),\n\t\t\t\texceeds the cumulative amount appropriated pursuant to ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4/sp:B", "@proposed": "true"}, {"#tail": " for the\n\t\t\t\tfiscal years 2014 through 2017, the excess amount shall be credited to the\n\t\t\t\tappropriation account of the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, {"#tail": " as provided in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", and shall be subtracted from the amount of fees that would\n\t\t\t\totherwise be authorized to be collected under this section pursuant to\n\t\t\t\tappropriation Acts for fiscal year 2018.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:1", "@proposed": "true"}], "#text": "If the sum of the cumulative amount of fees\n\t\t\t\tcollected under this section for fiscal years 2014 through 2016 and the amount\n\t\t\t\tof fees estimated to be collected under this section for fiscal year 2017\n\t\t\t\t(including any increased fee collections attributable to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Offset of overcollections", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id184e5d32ed594ca0bf3ffd409d100a1c", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, "#text": "For fiscal year 2016, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section shall be increased by the amount,\n\t\t\t\tif any, by which the amount collected under this section and appropriated for\n\t\t\t\tfiscal year 2014 falls below the amount of fees authorized for fiscal year 2014\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year 2016", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id104c67d7fb734180b2c3e8a8b1a865b4", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, "#text": "For fiscal year 2017, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section shall be increased by the amount,\n\t\t\t\tif any, by which the amount collected under this section and appropriated for\n\t\t\t\tfiscal year 2015 falls below the amount of fees authorized for fiscal year 2015\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year 2017", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id734261ab2af44cfe94750df06bcd059a", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "), shall be increased by the cumulative\n\t\t\t\tamount, if any, by which the amount collected under this section and\n\t\t\t\tappropriated for fiscal years 2016 and 2017 (including estimated collections\n\t\t\t\tfor fiscal year 2017) falls below the cumulative amount of fees authorized\n\t\t\t\tunder ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4/sp:A", "@proposed": "true"}, {"#tail": " for fiscal years 2016 and 2017.", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}], "#text": "For fiscal year 2018, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section (including any reduction in the\n\t\t\t\tauthorized amount under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year 2018", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idcce94146ddcd49a68e7c0fff8fff7738", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Recovery of collection shortfalls", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id59f70c4eda2b48a990d9c7b9ac351e11", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id26b0ce484bc3479abb5a8698156becd0", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not\n\t\t\t\treceive payment of a fee assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " within 30 days after it\n\t\t\t\tis due, such fee shall be treated as a claim of the United States Government\n\t\t\t\tsubject to ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Collection of unpaid fees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idc76efd22b8394a63903cc6e58714edf1", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or for a refund\n\t\t\t\tof any fee collected in accordance with ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d", "@proposed": "true"}, {"#tail": ", a person shall submit\n\t\t\t\tto the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " a written request for such waiver, reduction, or refund not\n\t\t\t\tlater than 180 days after such fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for\n\t\t\t\tconsideration for a waiver or reduction under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Written requests for waivers, reductions,\n\t\t\t\tand refunds", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idda35a235af3e4f8f9c8d98427c724d62", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", for officers,\n\t\t\t\temployees, and advisory committees not engaged in the process of the review of\n\t\t\t\tanimal drug applications, be reduced to offset the number of officers,\n\t\t\t\temployees, and advisory committees so engaged.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "This\n\t\t\t\tsection may not be construed to require that the number of full-time equivalent\n\t\t\t\tpositions in the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Construction", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id711bcda79b1640eda8809e41b0caa566", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n              ", "#text": "Abbreviated new animal drug\n\t\t\t\tapplications", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to the extent practicable, segregate the\n\t\t\t\treview of abbreviated new animal drug applications from the process for the\n\t\t\t\treview of animal drug applications; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id33baecf53cf54a36b38df809eb9926cb", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "adopt other administrative procedures to\n\t\t\t\tensure that review times of abbreviated new animal drug applications do not\n\t\t\t\tincrease from their current level due to activities under the user fee\n\t\t\t\tprogram.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idfcf2953d5595412b81d55a821bdc4cf6", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id16bb5dd7abb14d298f632d69081702f3", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id20bd7243cd6d4ec0bde67d3531977f61", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idE6F90BE0E0A74214B31A51B5B1004BEC"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idE57FA6A8996142F597DE8AD3F7810778", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 740A of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/379j-13", "#text": "21 U.S.C. 379j\u201313", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "104."}, "header": {"#tail": "\n        ", "#text": "Reauthorization; reporting\n\t\t\t requirements", "@display-inline": "yes-display-inline"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"@section-type": "subsequent-section", "#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "740A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reauthorization; reporting\n\t\t\t\trequirements", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report concerning the\n\t\t\t\tprogress of the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " in achieving the goals identified\n\t\t\t\tin the letters described in ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " toward expediting the animal drug development process and\n\t\t\t\tthe review of the new and supplemental animal drug applications and\n\t\t\t\tinvestigational animal drug submissions during such fiscal year, the future\n\t\t\t\tplans of the ", "@entity-type": "act", "#text": "section 101(b) of the Animal Drug User Fee\n\t\t\t\tAmendments of 2013", "@value": "Animal Drug User Fee Amendments of 2013/s:101/ss:b"}, {"#tail": " for meeting the goals, the review\n\t\t\t\ttimes for abbreviated new animal drug applications, and the administrative\n\t\t\t\tprocedures adopted by the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " to ensure that review\n\t\t\t\ttimes for abbreviated new animal drug applications are not increased from their\n\t\t\t\tcurrent level due to activities under the user fee program.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later\n\t\t\t\tthan 120 days after the end of each fiscal year during which fees are collected\n\t\t\t\tunder this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Performance report", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "ide710374a1b3649a282c6a20d66db3469", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report on the implementation of the\n\t\t\t\tauthority for such fees during such fiscal year and the use, by the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", of the fees collected during such fiscal year for which\n\t\t\t\tthe report is made.", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later than 120 days\n\t\t\t\tafter the end of each fiscal year during which fees are collected under this\n\t\t\t\tpart, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fiscal report", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id036e8e685fd2433a9a150752fc6853c9", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the reports\n\t\t\t\trequired under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:a", "@proposed": "true"}, {"#tail": " available to the public on the Internet\n\t\t\t\tWeb site of the Food and Drug Administration.", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:b", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Public availability", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id70c74929fa794ceda549be2e4bcdb860", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reauthorization", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to the\n\t\t\t\tgoals, and plans for meeting the goals, for the process for the review of\n\t\t\t\tanimal drug applications for the first 5 fiscal years after fiscal year 2018,\n\t\t\t\tand for the reauthorization of this part for such fiscal years, the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": "\n\t\t\t\tshall consult with\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping recommendations to present to the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Consultation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id57095eef82914448879892c2b5cfe99c", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor,\n\t\t\t\tand Pensions of the Senate", "@entity-id": "SSHR00"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ide111af8ca37e4693b84ca1626c83cd47", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the\n\t\t\t\tHouse of Representatives", "@entity-id": "HIF00"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id448d41d83bf441b3a1391bff9bad9137", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "scientific and academic experts;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id07b24380644a4aabae82feedc049e120", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "veterinary professionals;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id9008aebf19cc479e8b2fd3c7e20d0f68", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "representatives of patient and consumer\n\t\t\t\tadvocacy groups; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idd5d4740bfc954e24b85d86514a3b9cf6", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the regulated industry.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idef604a0ab22e4a57b6ea8698e136787b", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to beginning negotiations with the\n\t\t\t\tregulated industry on the reauthorization of this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prior public input", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id89f90dbdd5e04ec2aa435447045e507b", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice in the Federal Register\n\t\t\t\trequesting public input on the reauthorization;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idd1d66eb433a645658f2b64fc5667fa96", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:a", "@proposed": "true"}, "#text": "hold a public meeting at which the public\n\t\t\t\tmay present its views on the reauthorization, including specific suggestions\n\t\t\t\tfor changes to the goals referred to in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id269baaa080b84fef91902ca8d2aa46a3", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period of 30 days after the\n\t\t\t\tpublic meeting to obtain written comments from the public suggesting changes to\n\t\t\t\tthis part; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id7496a4dca3e8451f85d7842dd3216a64", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish the comments on the Food and Drug\n\t\t\t\tAdministration\u2019s Internet Web site.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id67d013b5e00b4c48a9e36b7df2599129", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\thold discussions with representatives of veterinary, patient, and consumer\n\t\t\t\tadvocacy groups to continue discussions of their views on the reauthorization\n\t\t\t\tand their suggestions for changes to this part as expressed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:2", "@proposed": "true"}], "#text": "Not less frequently than once every 4\n\t\t\t\tmonths during negotiations with the regulated industry, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Periodic consultation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id9230d0a90c734dc5a1058fe99e46cfa9", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "After\n\t\t\t\tnegotiations with the regulated industry, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Public review of\n\t\t\t\trecommendations", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id57f685acb120400697565bc2d0b43fbc", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the Congressional committees specified in such\n\t\t\t\tparagraph;", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:1", "@proposed": "true"}, "#text": "present the recommendations developed under\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idf9b35f1dc4d6427895456dc260e75775", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such recommendations in the Federal\n\t\t\t\tRegister;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idcc769eebd7dc40a8bbe143ac09353cba", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for a period of 30 days for the\n\t\t\t\tpublic to provide written comments on such recommendations;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idac581df369e847d89cedc615ed466f56", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a meeting at which the public may\n\t\t\t\tpresent its views on such recommendations; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id2cfd442b7abd45d9b39640e83aaaf812", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "after consideration of such public views\n\t\t\t\tand comments, revise such recommendations as necessary.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id6f12127e7ba64095b14fef4d8d658e5a", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall transmit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the revised\n\t\t\t\trecommendations under ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " a summary of the views and comments\n\t\t\t\treceived under such paragraph, and any changes made to the recommendations in\n\t\t\t\tresponse to such views and comments.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:4", "@proposed": "true"}], "#text": "Not later\n\t\t\t\tthan January 15, 2018, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Transmittal of\n\t\t\t\trecommendations", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idd01a91d0528f42da94f26ccb08545148", "@commented": "no"}, {"#tail": "\n            ", "@id": "ida076c7807f1d43238f245a5a5e6d8458", "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Minutes of negotiation meetings", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to ", "@entity-type": "act", "#text": "paragraphs (1) through (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:1..5", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall\n\t\t\t\tmake publicly available, on the Internet Web site of the Food and Drug\n\t\t\t\tAdministration, minutes of all negotiation meetings conducted under this\n\t\t\t\tsubsection between the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the regulated\n\t\t\t\tindustry.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Before presenting the recommendations\n\t\t\t\tdeveloped under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Public availability", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id9cb0747cfca04ad1ab544a53081714dc", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall summarize any substantive proposal made by any party to the\n\t\t\t\tnegotiations as well as significant controversies or differences of opinion\n\t\t\t\tduring the negotiations and their\n\t\t\t\tresolution.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:6/sp:A", "@proposed": "true"}, "#text": "The minutes described under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Content", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id815564b6c0a64e78b0bf983cb962efa2", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idebefb335a8394bb6b022f739b5489539", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id169ab2424afb43bba1e9aa0871d919b9", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id42045B5453184AC8B1E58DE58F9C326B"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idF95379A251544E6E81CF9BBCFDFA1C6E", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for filing with respect to assessing and collecting any fee\n\t\t\t required by such part for a fiscal year prior to fiscal year 2014.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}, "#text": "Notwithstanding the\n\t\t\t amendments made by this title, ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as in effect\n\t\t\t on the day before the date of the enactment of this title, shall continue to be\n\t\t\t in effect with respect to animal drug applications and supplemental animal drug\n\t\t\t applications (as defined in such part as of such day) that on or after October\n\t\t\t 1, 2008, but before October 1, 2013, were accepted by the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part 4 of subchapter C of chapter VII of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201311 et seq.", "@value": "usc/21/379j\u201311/etseq"}, "@parsable-cite": "usc/21/379j-11", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "105."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idba28b0f6449e4cf594c392846a403b7d", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", as amended by this\n\t\t\t title, shall be assessed for all animal drug applications and supplemental\n\t\t\t animal drug applications received on or after October 1, 2013, regardless of\n\t\t\t the date of the enactment of this Act.", "@entity-type": "act", "#text": "part 4 of subchapter C of\n\t\t\t chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, "#text": "The amendments made by\n\t\t\t this title shall take effect on October 1, 2013, or the date of enactment of\n\t\t\t this Act, whichever is later, except that fees under ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "106."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idc9d1267aec5c4c19b7d4aa9c166e8eee", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "107."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Sunset dates", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease\n\t\t\t to be effective October 1, 2018.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 740 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201312", "@value": "usc/21/379j\u201312", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-12", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Authorization", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "ida4a641c87d6f448487f5da62d52db76d", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease to be effective January 31, 2019.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 740A of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201313", "@value": "usc/21/379j\u201313", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-13", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Reporting requirements", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id4cf78229349d409dbfb2ecdbcbe4b405", "@commented": "no"}, {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Previous sunset provision", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 108 of the Animal Drug User Fee Amendments of\n\t\t\t 2008", "@value": "Animal Drug User Fee Amendments of 2008/s:108"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "pl/110/316", "#text": "Public Law 110\u2013316", "@legal-doc": "public-law"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "idF96D025B9B954D67B403EB31E8339400", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 108", "@value": "Animal Drug User Fee Amendments of 2008/s:108"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended in the table of contents in section 1, by striking the item\n\t\t\t relating to ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Animal Drug User Fee Amendments of 2008", "@value": "Animal Drug User Fee Amendments of 2008"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public Law\n\t\t\t 110\u2013316", "@value": "public-law/110/316"}], "@entity-type": "law-citation", "#text": "\n              "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Conforming amendment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id704437d4593445a1b663af92ade5d290", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id4a9f8594497e4531a4856d553c4bbacf", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Effective November 18, 2003, ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 5 of the\n\t\t\t Animal Drug User Fee Act of 2003", "@value": "Animal Drug User Fee Act of 2003/s:5"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "@parsable-cite": "pl/108/130", "#text": "Public Law 108\u2013130", "@legal-doc": "public-law"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(d)"}, "header": {"#tail": "\n          ", "#text": "Technical clarification", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id9d1d603607f54f548b231acd56ef8fc7", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id0b82b2aad4a449f1a2d259581c5c328c", "@commented": "no"}], "enum": {"#tail": "\n      ", "#text": "I"}, "#tail": "\n    ", "header": {"#tail": "\n\t\t\t", "#text": "Fees relating to animal drugs", "@display-inline": "yes-display-inline"}, "#text": "\n      ", "@id": "idCAB9CAD96B1741ABBCE4EB6FD7B2A456", "@commented": "no"}, {"@level-type": "subsequent", "section": [{"@section-type": "subsequent-section", "#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "201."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Short title; finding", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "#text": "Animal Generic Drug User Fee Amendments of 2013"}, "#text": "This title may be cited as the\n\t\t\t ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Short title", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id5B7258CB595642B195BCA087E66A0A86", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t to the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Chairman of the Committee on Energy and Commerce of the House of\n\t\t\t Representatives", "@entity-id": "HIF00"}, {"#tail": " as set forth in the Congressional Record.", "@entity-type": "committee", "#text": "Chairman of the Committee on Health, Education, Labor,\n\t\t\t and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "The fees authorized by this title will be\n\t\t\t dedicated toward expediting the generic new animal drug development process and\n\t\t\t the review of abbreviated applications for generic new animal drugs,\n\t\t\t supplemental abbreviated applications for generic new animal drugs, and\n\t\t\t investigational submissions for generic new animal drugs as set forth in the\n\t\t\t goals identified in the letters from the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Finding", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id3676933E1331421F958CC0D6921A8692", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id7BD7ADAD8E32489AACA44A75A67EB6D3", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 741 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:741"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/379j-21", "#text": "21 U.S.C. 379j\u201321", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "202."}, "header": {"#tail": "\n        ", "#text": "Authority to assess and use generic new\n\t\t\t animal drug fees", "@display-inline": "yes-display-inline"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"@section-type": "subsequent-section", "#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "741."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Authority to assess and use generic new\n\t\t\t\tanimal drug fees", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall assess and collect fees in accordance with this section as\n\t\t\t\tfollows:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning with respect to fiscal year 2009, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Types of fees", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "@id": "idd033dcc8694346e9bfea5f744da4e5e8", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Abbreviated application fee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such an application.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "Each person that submits, on or after July 1, 2008, an\n\t\t\t\tabbreviated application for a generic new animal drug shall be subject to a fee\n\t\t\t\tas established in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id64e19cdb78e846eb9618119a878bcb6e", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be due upon submission of the\n\t\t\t\tabbreviated application.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tfee required by ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "iddf1c179e7f89415cb864455241acc50c", "@commented": "no"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "If an abbreviated application was submitted by a\n\t\t\t\tperson that paid the fee for such application, was accepted for filing, and was\n\t\t\t\tnot approved or was withdrawn (without a waiver or refund), the submission of\n\t\t\t\tan abbreviated application for the same product by the same person (or the\n\t\t\t\tperson\u2019s licensee, assignee, or successor) shall not be subject to a fee under\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Previously filed application", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idf1a2fedb5ba147c694c99c050050e03d", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tand submitted on or after October 1, 2013 shall be subject to a fee equal to 50\n\t\t\t\tpercent of the amount of the abbreviated application fee established in\n\t\t\t\t", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}], "#text": "An\n\t\t\t\tabbreviated application which is subject to the criteria in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Certain abbreviated applications involving\n\t\t\t\tcombination animal drugs", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idf6c5602f895c487eab23ff78be8b7782", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idcacc9bc274074a8db26b6e5af3176db4", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall refund 75\n\t\t\t\tpercent of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for any abbreviated application\n\t\t\t\twhich is refused for filing.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if application refused for\n\t\t\t\tfiling", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id700c5176ac0f4e729575ac629c0538dd", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may refund the fee or portion of\n\t\t\t\tthe fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if no substantial work was performed on the\n\t\t\t\tapplication after the application was filed. The ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": " shall have the sole\n\t\t\t\tdiscretion to refund the fee under this subparagraph. A determination by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " concerning a refund under this subparagraph shall not be\n\t\t\t\treviewable.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an abbreviated application is withdrawn\n\t\t\t\tafter the application was filed, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if application\n\t\t\t\twithdrawn", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id52f66165be4740efa589fcf66f4f4231", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "@id": "idfd11ae881c8a4a8395dfe4a2a77d51bd", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Generic new animal drug product\n\t\t\t\tfee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall pay for each such generic\n\t\t\t\tnew animal drug product the annual fee established in ", "@commented": "no"}, "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as\n\t\t\t\tthe applicant in an abbreviated application or supplemental abbreviated\n\t\t\t\tapplication for a generic new animal drug product which has been submitted for\n\t\t\t\tlisting under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idAAC47F3697D44D29AC81C4CF403D37F4", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an abbreviated application\n\t\t\t\tor supplemental abbreviated application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2008, had pending before the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id22C71518F6FC452C98C0C0B94BC7D85A", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "iddab15399c61c4d0a8035ebba52405e39", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or is submitted for relisting under ", "@entity-type": "act", "#text": "section\n\t\t\t\t510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the generic new animal\n\t\t\t\tdrug product has been withdrawn from listing and relisted. After such fee is\n\t\t\t\tpaid for that fiscal year, such fee shall be due each subsequent fiscal year\n\t\t\t\tthat the product remains listed, upon the later of\u2014", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "Such fee shall be payable for the fiscal year in which the\n\t\t\t\tgeneric new animal drug product is first submitted for listing under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day after the date of\n\t\t\t\tenactment of an appropriations Act providing for the collection and obligation\n\t\t\t\tof fees for such fiscal year under this section; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id7bddf23393ad4b39b10d88411c43cad6", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id8830eb3b7c8748c193ac55db8ec8f2cd", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Payment; fee due date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id211fc9136c594c11ba4e35b782475d93", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such fee shall be paid only once for each\n\t\t\t\tgeneric new animal drug product for a fiscal year in which the fee is\n\t\t\t\tpayable.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id891f78304ddc40e0a2671e398b8eb9d8", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "@id": "id6557cb8279b544cbb0c55ab780769fc7", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Generic new animal drug sponsor\n\t\t\t\tfee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall be assessed an annual\n\t\t\t\tgeneric new animal drug sponsor fee as established under ", "@commented": "no"}, "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who meets the definition of a generic new\n\t\t\t\tanimal drug sponsor within a fiscal year; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id3d9927c3f8ca4d9a86d2ca1c3fea48ce", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an abbreviated application,\n\t\t\t\ta supplemental abbreviated application, or an investigational\n\t\t\t\tsubmission,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2008, had pending before the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id6ed44938f43440c286c689f69dcdbf4d", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "iddd8b31386bc8451f9cafcf8812045a00", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Such fee shall be due each fiscal year upon\n\t\t\t\tthe later of\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day after the date of\n\t\t\t\tenactment of an appropriations Act providing for the collection and obligation\n\t\t\t\tof fees for such fiscal year under this section; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idf3f3c6043fcd42a8adc1d78c4f59d909", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id7e94ffff524241c29c0f544d1b328f44", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Payment; fee due date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id973e315abc5b4c83ba5c0ca8a28c2dd4", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each generic new animal drug sponsor shall\n\t\t\t\tpay only 1 such fee each fiscal year, as follows:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with more than 6 approved\n\t\t\t\tabbreviated applications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "100 percent of the\n\t\t\t\tamount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id1e219392f0c9409ba632949563e83795", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with more than 1 and fewer than 7\n\t\t\t\tapproved abbreviated applications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "75 percent of the\n\t\t\t\tamount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "ida54fb62d685f40789260736565e74c79", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with 1 or fewer approved abbreviated\n\t\t\t\tapplications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "50 percent of\n\t\t\t\tthe amount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "idb071d68510344c6387857401259a5fca", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Amount of fee", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id5beff016510541e2b04af8839e31f8b0", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idA929B54902514A168CBA747A059C7C37", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f", "@proposed": "true"}, {"#tail": ", the fees\n\t\t\t\trequired under ", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g", "@proposed": "true"}, {"#tail": " shall be established to generate fee revenue\n\t\t\t\tamounts as follows:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}], "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fee amounts", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\t$1,832,000 for fiscal year 2014, $1,736,000 for fiscal year 2015, $1,857,000\n\t\t\t\tfor fiscal year 2016, $1,984,000 for fiscal year 2017, and $2,117,000 for\n\t\t\t\tfiscal year 2018.", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1", "@proposed": "true"}, "#text": "The total fee revenues to be\n\t\t\t\tcollected in abbreviated application fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Total fee revenues for application\n\t\t\t\tfees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idb58dd700a9284e1a9d8f8fc7404cc390", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\t$2,748,000 for fiscal year 2014, $2,604,000 for fiscal year 2015, $2,786,000\n\t\t\t\tfor fiscal year 2016, $2,976,000 for fiscal year 2017, and $3,175,000 for\n\t\t\t\tfiscal year 2018.", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:2", "@proposed": "true"}, "#text": "The total fee revenues to be collected\n\t\t\t\tin generic new animal drug product fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Total fee revenues for product\n\t\t\t\tfees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id5669b7ac40eb48b79412de7b1b69dc28", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\t$2,748,000 for fiscal year 2014, $2,604,000 for fiscal year 2015, $2,786,000\n\t\t\t\tfor fiscal year 2016, $2,976,000 for fiscal year 2017, and $3,175,000 for\n\t\t\t\tfiscal year 2018.", "@entity-type": "act", "#text": "subsection (a)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:3", "@proposed": "true"}, "#text": "The total fee revenues to be collected\n\t\t\t\tin generic new animal drug sponsor fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Total fee revenues for sponsor\n\t\t\t\tfees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id051a16f1c29d483f8b09af6298f78f2a", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id1c956cf667cb4f9ca80915cb7e2b8665", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Annual fee setting; adjustments", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, 60 days before the start\n\t\t\t\tof each fiscal year beginning after September 30, 2008, for that fiscal year,\n\t\t\t\tabbreviated application fees, generic new animal drug sponsor fees, and generic\n\t\t\t\tnew animal drug product fees, based on the revenue amounts established under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the adjustments provided under this subsection.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:b", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Annual fee setting", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idb497e2af466147f28ffd9808017b1da2", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The fee revenues shall be adjusted each\n\t\t\t\tfiscal year after fiscal year 2014 to reflect changes in review workload. With\n\t\t\t\trespect to such adjustment:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Workload adjustment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id2b530be4ba344a7c8472d1472619bf1e", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based on a weighted average of the change\n\t\t\t\tin the total number of abbreviated applications for generic new animal drugs,\n\t\t\t\tmanufacturing supplemental abbreviated applications for generic new animal\n\t\t\t\tdrugs, investigational generic new animal drug study submissions, and\n\t\t\t\tinvestigational generic new animal drug protocol submissions submitted to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall publish in the Federal Register the fees\n\t\t\t\tresulting from this adjustment and the supporting methodologies.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "This adjustment\n\t\t\t\tshall be determined by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idce55f0013c2843629bc3559c17c3ff6d", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:b", "@proposed": "true"}, "#text": "Under no\n\t\t\t\tcircumstances shall this workload adjustment result in fee revenues for a\n\t\t\t\tfiscal year that are less than the fee revenues for that fiscal year\n\t\t\t\testablished in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idc839937aeed44f2398c5cd749fee45df", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in addition\n\t\t\t\tto other adjustments under this subsection, further increase the fees under\n\t\t\t\tthis section, if such an adjustment is necessary, to provide for up to 3 months\n\t\t\t\tof operating reserves of carryover user fees for the process for the review of\n\t\t\t\tabbreviated applications for generic new animal drugs for the first 3 months of\n\t\t\t\tfiscal year 2019. If the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has carryover balances\n\t\t\t\tfor the process for the review of abbreviated applications for generic new\n\t\t\t\tanimal drugs in excess of 3 months of such operating reserves, then this\n\t\t\t\tadjustment shall not be made. If this adjustment is necessary, then the\n\t\t\t\trationale for the amount of the increase shall be contained in the annual\n\t\t\t\tnotice setting fees for fiscal year 2018.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "For fiscal year 2018, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Final year adjustment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id79f461a2102d4ba5ae16865000a62050", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The total amount of fees charged, as\n\t\t\t\tadjusted under this subsection, for a fiscal year may not exceed the total\n\t\t\t\tcosts for such fiscal year for the resources allocated for the process for the\n\t\t\t\treview of abbreviated applications for generic new animal drugs.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Limit", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idab55f7fd91134a609c1f3553647115d0", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idf6f2311b96bd43de92f540e7ea172f1b", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant a waiver from or a reduction\n\t\t\t\tof 1 or more fees assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " finds that\n\t\t\t\tthe generic new animal drug is intended solely to provide for a minor use or\n\t\t\t\tminor species indication.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n              ", "#text": "Fee waiver or reduction", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id474bf912dc054a5394e194a0c8ccd9d1", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be\n\t\t\t\tconsidered incomplete and shall not be accepted for filing by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tuntil all fees owed by such person have been paid. An investigational\n\t\t\t\tsubmission for a generic new animal drug that is submitted by a person subject\n\t\t\t\tto fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall be considered incomplete and shall not be\n\t\t\t\taccepted for review by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person have\n\t\t\t\tbeen paid. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may discontinue review of any abbreviated application\n\t\t\t\tfor a generic new animal drug, supplemental abbreviated application for a\n\t\t\t\tgeneric new animal drug, or investigational submission for a generic new animal\n\t\t\t\tdrug from a person if such person has not submitted for payment all fees owed\n\t\t\t\tunder this section by 30 days after the date upon which they are due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An abbreviated application for a generic new\n\t\t\t\tanimal drug submitted by a person subject to fees under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Effect of failure To pay fees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idd9cb7aedcb3d4858b093b99de0a4b2f7", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment of fees", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year beginning after\n\t\t\t\tfiscal year 2008 unless appropriations for salaries and expenses of the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " for such fiscal year (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) are equal to or greater than the amount of\n\t\t\t\tappropriations for the salaries and expenses of the ", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, {"#tail": " for the fiscal year 2003 (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) multiplied by the adjustment factor\n\t\t\t\tapplicable to the fiscal year involved.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "Fees\n\t\t\t\tmay not be assessed under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id9edc3a6a8b1344e084165fab3c9608df", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not assess fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " during any portion of a\n\t\t\t\tfiscal year because of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " and if at a later date in such fiscal year\n\t\t\t\tthe ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f/p:1", "@proposed": "true"}, {"#tail": " may assess such fees, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect such\n\t\t\t\tfees, without any modification in the rate, for abbreviated applications,\n\t\t\t\tgeneric new animal drug sponsors, and generic new animal drug products at any\n\t\t\t\ttime in such fiscal year notwithstanding the provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\trelating to the date fees are to be paid.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Authority", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id9a9badbc35d5453db9629e9ff10fb752", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idb22582a4cdf04bd8babc79b17fd0c976", "@commented": "no"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Crediting and availability of fees", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", fees authorized under\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:C", "@proposed": "true"}, {"#tail": " shall be collected and available for obligation only to the\n\t\t\t\textent and in the amount provided in advance in appropriations Acts. Such fees\n\t\t\t\tare authorized to be appropriated to remain available until expended. Such sums\n\t\t\t\tas may be necessary may be transferred from the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tsalaries and expenses appropriation account without fiscal year limitation to\n\t\t\t\tsuch appropriation account for salary and expenses with such fiscal year\n\t\t\t\tlimitation. The sums transferred shall be available solely for the process for\n\t\t\t\tthe review of abbreviated applications for generic new animal drugs.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id5b018b8f434347bcbbc30f69a9b09049", "@commented": "no"}, {"#tail": "\n              ", "@id": "idc9b1a94605274f0e907affff1e4955c1", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collections and appropriation acts", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fees authorized by this section\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall be\n\t\t\t\tcollected and available in each fiscal year in an amount not to exceed the\n\t\t\t\tamount specified in appropriation Acts, or otherwise made available for\n\t\t\t\tobligation for such fiscal year; and", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:C", "@proposed": "true"}, "#text": "subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id347363eabb5742ed8aa7e3ebe4710571", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be\n\t\t\t\tengaged in such process) over such costs, excluding costs paid from fees\n\t\t\t\tcollected under this section, for fiscal year 2008 multiplied by the adjustment\n\t\t\t\tfactor.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "shall be\n\t\t\t\tavailable to defray increases in the costs of the resources allocated for the\n\t\t\t\tprocess for the review of abbreviated applications for generic new animal drugs\n\t\t\t\t(including increases in such costs for an additional number of full-time\n\t\t\t\tequivalent positions in the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "ide9db51ba72164628b296549fe1ed056a", "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id9062c4e0e546425985494248120ca399", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered to have met the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in any fiscal year if the costs funded by appropriations and allocated\n\t\t\t\tfor the process for the review of abbreviated applications for generic new\n\t\t\t\tanimal drugs\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "are not more than 3 percent below the level\n\t\t\t\tspecified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "id4fb5d0dd6a4f489e9fecaeae3097a116", "@commented": "no"}, {"#tail": "\n                ", "@id": "id64f07a2293324659bd822cce3a163897", "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and fees assessed for the fiscal year\n\t\t\t\tfollowing the subsequent fiscal year are decreased by the amount in excess of 3\n\t\t\t\tpercent by which such costs fell below the level specified in ", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "are more than 3 percent below the level\n\t\t\t\tspecified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id1577C26DF6A14192927D1A054851AF0E", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "such costs are not more than 5 percent\n\t\t\t\tbelow the level specified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@display-inline": "no-display-inline", "#text": "\n                      ", "@id": "id655045F5D8054D87866A62190C14BEE1", "@commented": "no"}], "@commented": "no"}], "header": {"#tail": "\n                  ", "#text": "Compliance", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idd23dbbcd51834e5889d81909ce62b7ae", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in accordance with authority provided in advance in a prior\n\t\t\t\tyear appropriations Act.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Payment of fees authorized under this\n\t\t\t\tsection for a fiscal year, prior to the due date for such fees, may be accepted\n\t\t\t\tby the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Provision for early payments", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id19580c37f8ff4d26ad08a56edbba00a9", "@commented": "no"}], "@commented": "no"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "paragraph", "#text": "as adjusted to reflect adjustments in\n\t\t\t\tthe total fee revenues made under this section and changes in the total amounts\n\t\t\t\tcollected by abbreviated application fees, generic new animal drug sponsor\n\t\t\t\tfees, and generic new animal drug product fees.", "@commented": "no"}, "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "\n                ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n              ", "@entity-type": "auth-auth-approp", "#text": "There are authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}property": {"#tail": "\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "this section", "@value": "Federal Food, Drug, and Cosmetic Act/s:741", "@proposed": "true"}, "#text": "for fees\n\t\t\t\tunder ", "@name": "purpose"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorization of\n\t\t\t\tappropriations", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idabfe73e158f249abb0232b9ef342c788", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$7,328,000 for\n\t\t\t\tfiscal year 2014", "@amount": "7328000", "@year": "2014"}, "#text": "\n                    ", "@display-inline": "yes-display-inline"}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                    "}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idac5784dfb4ef44e893b26b7cde670052", "@commented": "no"}, {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$6,944,000 for\n\t\t\t\tfiscal year 2015", "@amount": "6944000", "@year": "2015"}, "#text": "\n                    ", "@display-inline": "yes-display-inline"}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                    "}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idd10cd8580e5347f9ad83be3857ca567e", "@commented": "no"}, {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$7,429,000 for\n\t\t\t\tfiscal year 2016", "@amount": "7429000", "@year": "2016"}, "#text": "\n                    ", "@display-inline": "yes-display-inline"}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                    "}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idef95bb14183f45168b8ef8e5500fc69d", "@commented": "no"}, {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "; and", "#text": "$7,936,000 for\n\t\t\t\tfiscal year 2017", "@amount": "7936000", "@year": "2017"}, "#text": "\n                    ", "@display-inline": "yes-display-inline"}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(D)"}, "#text": "\n                    "}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id70956af7bdf146d9bb768f9aee6dc5a5", "@commented": "no"}, {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$8,467,000 for\n\t\t\t\tfiscal year 2018", "@amount": "8467000", "@year": "2018"}, "#text": "\n                    ", "@display-inline": "yes-display-inline"}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(E)"}, "#text": "\n                    "}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id4d2c2be7c3eb425d86e3526101b3071c", "@commented": "no"}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for the fiscal years 2014 through 2017, the\n\t\t\t\texcess amount shall be credited to the appropriation account of the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:3", "@proposed": "true"}, {"#tail": " as provided in ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}, {"#tail": ", and shall be subtracted from\n\t\t\t\tthe amount of fees that would otherwise be authorized to be collected under\n\t\t\t\tthis section pursuant to appropriation Acts for fiscal year 2018.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:1", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe sum of the cumulative amount of fees collected under this section for the\n\t\t\t\tfiscal years 2014 through 2016 and the amount of fees estimated to be collected\n\t\t\t\tunder this section for fiscal year 2017 exceeds the cumulative amount\n\t\t\t\tappropriated under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Offset", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id2aa2ca2dae8c4cb69c85a6a8d27d64fe", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idfb4a0834e4e44bca971de9ef32b1cb8a", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not\n\t\t\t\treceive payment of a fee assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " within 30 days after it\n\t\t\t\tis due, such fee shall be treated as a claim of the United States Government\n\t\t\t\tsubject to ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Collection of unpaid fees", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id985851c562cc46b7bee05be65b7538b3", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or for a refund\n\t\t\t\tof any fee collected in accordance with ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:d", "@proposed": "true"}, {"#tail": ", a person shall submit\n\t\t\t\tto the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " a written request for such waiver, reduction, or refund not\n\t\t\t\tlater than 180 days after such fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for\n\t\t\t\tconsideration for a waiver or reduction under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Written requests for waivers, reductions,\n\t\t\t\tand refunds", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id5e73490d23ae4a99bb861fae59b1c633", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", for officers,\n\t\t\t\temployees, and advisory committees not engaged in the process of the review of\n\t\t\t\tabbreviated applications for generic new animal drugs, be reduced to offset the\n\t\t\t\tnumber of officers, employees, and advisory committees so engaged.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "This\n\t\t\t\tsection may not be construed to require that the number of full-time equivalent\n\t\t\t\tpositions in the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Construction", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id29448b8b6ce54925be18ca43cca6dc34", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ":", "@entity-type": "act", "#text": "section 742", "@value": "Federal Food, Drug, and Cosmetic Act/s:742", "@proposed": "true"}, "#text": "In\n\t\t\t\tthis section and ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n              ", "#text": "Definitions", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". Such\n\t\t\t\tterm does not include a supplemental abbreviated application for a generic new\n\t\t\t\tanimal drug.", "@entity-type": "act", "#text": "section 512(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:2"}, "quote": [{"#tail": " and\n\t\t\t\t", "#text": "abbreviated application for a generic new animal drug"}, {"#tail": " mean an abbreviated application for the\n\t\t\t\tapproval of any generic new animal drug submitted under ", "#text": "abbreviated application"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "The terms\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Abbreviated application for a generic new\n\t\t\t\tanimal drug", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id9e789c630f534fc1a17705f4711f20db", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tapplicable to a fiscal year is the Consumer Price Index for all urban consumers\n\t\t\t\t(all items; United States city average) for October of the preceding fiscal\n\t\t\t\tyear divided by\u2014", "#text": "adjustment factor"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Adjustment factor", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "ida30b674c75294162b443730015f16a0c", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", such Index for October 2002; and", "@entity-type": "act", "#text": "subsection (f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f/p:1", "@proposed": "true"}, "#text": "for purposes of\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "iddc627bb6c4f14deead951018b3911e85", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", such Index for October 2007.", "@entity-type": "act", "#text": "subsection (g)(2)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "for purposes of\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idf3c77447412d4cf6b311d82382553bcc", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the expenses in connection with the\n\t\t\t\tprocess for the review of abbreviated applications for generic new animal drugs\n\t\t\t\tfor\u2014", "#text": "costs of\n\t\t\t\tresources allocated for the process for the review of abbreviated applications\n\t\t\t\tfor generic new animal drugs"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Costs of resources allocated for the\n\t\t\t\tprocess for the review of abbreviated applications for generic new animal\n\t\t\t\tdrugs", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id5673217cf52d44d59d2788efbdfd28dc", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", contractors of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", advisory committees consulted with respect to the review of\n\t\t\t\tspecific abbreviated applications, supplemental abbreviated applications, or\n\t\t\t\tinvestigational submissions, and costs related to such officers, employees,\n\t\t\t\tcommittees, and contractors, including costs for travel, education, and\n\t\t\t\trecruitment and other personnel activities;", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "officers and\n\t\t\t\temployees of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idb6172e6188464671aba1cd8e4c8cf6dd", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "management of information, and the\n\t\t\t\tacquisition, maintenance, and repair of computer resources;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id284f904c024147579ef83105e08e3c5e", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "leasing, maintenance, renovation, and\n\t\t\t\trepair of facilities and acquisition, maintenance, and repair of fixtures,\n\t\t\t\tfurniture, scientific equipment, and other necessary materials and supplies;\n\t\t\t\tand", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id86ce78a8844748a0b5cc9bb6cc761dff", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "collecting fees under this section and\n\t\t\t\taccounting for resources allocated for the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id17faa74bca3b4c2aa225ba900b4a3bc2", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans, with respect to a generic new animal drug product, a finished dosage\n\t\t\t\tform which is approved for administration to an animal without substantial\n\t\t\t\tfurther manufacturing. Such term includes generic new animal drug products\n\t\t\t\tintended for mixing in animal feeds.", "#text": "final dosage form"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Final dosage form", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id20b1eb3b785c4ec390293f0af646feab", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a new animal drug that is the subject of an abbreviated\n\t\t\t\tapplication.", "#text": "generic new animal\n\t\t\t\tdrug"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Generic new animal drug", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id272826959c1744dcb5bed307340b9b2c", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means each specific strength or\n\t\t\t\tpotency of a particular active ingredient or ingredients in final dosage form\n\t\t\t\tmarketed by a particular manufacturer or distributor, which is uniquely\n\t\t\t\tidentified by the labeler code and product code portions of the national drug\n\t\t\t\tcode, and for which an abbreviated application for a generic new animal drug or\n\t\t\t\ta supplemental abbreviated application has been approved.", "#text": "generic new animal drug product"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Generic new animal drug\n\t\t\t\tproduct", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id58927ba3757e4d39a57beee909079257", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or a person who has\n\t\t\t\tsubmitted an investigational submission for a generic new animal drug that has\n\t\t\t\tnot been terminated or otherwise rendered inactive by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means either an applicant named in an abbreviated application\n\t\t\t\tfor a generic new animal drug that has not been withdrawn by the applicant and\n\t\t\t\tfor which approval has not been withdrawn by the ", "#text": "generic new animal drug\n\t\t\t\tsponsor"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Generic new animal drug\n\t\t\t\tsponsor", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id44ea039cf7554eab87ade377979465d6", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "quote": {"#tail": " mean\u2014", "#text": "investigational submission"}, "term": {"#tail": " and\n\t\t\t\t", "#text": "investigational submission for a generic new animal drug"}, "#text": "The terms\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n                ", "#text": "Investigational submission for a generic\n\t\t\t\tnew animal drug", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idfde766ad6a094af99ff2af00b289ee00", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a generic new\n\t\t\t\tanimal drug intended to be the subject of an abbreviated application or a\n\t\t\t\tsupplemental abbreviated application; or", "@entity-type": "act", "#text": "section 512(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:j"}, "#text": "the filing of a\n\t\t\t\tclaim for an investigational exemption under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id5b080929c7b0475391d5f38fee5aaf53", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to evaluate the safety or\n\t\t\t\teffectiveness of a generic new animal drug in the event of the filing of an\n\t\t\t\tabbreviated application or supplemental abbreviated application for such\n\t\t\t\tdrug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the submission of\n\t\t\t\tinformation for the purpose of enabling the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id7b92f5fd2e404d55a274cd8bd2ab2253", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ").", "@entity-type": "act", "#text": "section 735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " includes an affiliate thereof (as such term is defined\n\t\t\t\tin ", "#text": "person"}, "#text": "The\n\t\t\t\tterm ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n                ", "#text": "Person", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id762a596bef624fce92f8f6688bb0ef3b", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means the following activities\n\t\t\t\tof the ", "#text": "process for the review of abbreviated\n\t\t\t\tapplications for generic new animal drugs"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n                ", "#text": "Process for the review of abbreviated\n\t\t\t\tapplications for generic new animal drugs", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idcef769cd12b94d8790c5c79ae91e12ce", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The activities necessary for the review of\n\t\t\t\tabbreviated applications, supplemental abbreviated applications, and\n\t\t\t\tinvestigational submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id1d28224fcbba42f78f55cd33f84cdb7f", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The issuance of action letters which\n\t\t\t\tapprove abbreviated applications or supplemental abbreviated applications or\n\t\t\t\twhich set forth in detail the specific deficiencies in abbreviated\n\t\t\t\tapplications, supplemental abbreviated applications, or investigational\n\t\t\t\tsubmissions and, where appropriate, the actions necessary to place such\n\t\t\t\tapplications, supplemental applications, or submissions in condition for\n\t\t\t\tapproval.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idca7ad63ac97d4c4b9af9c27fbc472598", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " review of pending abbreviated applications, supplemental\n\t\t\t\tabbreviated applications, and investigational submissions.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}, "#text": "The inspection of\n\t\t\t\tgeneric new animal drug establishments and other facilities undertaken as part\n\t\t\t\tof the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id6b7613a72e984e13a81702dc0a34d4d6", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Monitoring of research conducted in\n\t\t\t\tconnection with the review of abbreviated applications, supplemental\n\t\t\t\tabbreviated applications, and investigational submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id27e26d94202a4fb1a715b9901fb0b98e", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The development of regulations and policy\n\t\t\t\trelated to the review of abbreviated applications, supplemental abbreviated\n\t\t\t\tapplications, and investigational submissions.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id1f297d9205094f2e9f3f0ec77f835af8", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Development of standards for products\n\t\t\t\tsubject to review.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idbbdb71b7975c4d2cae850f74a353f26d", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Meetings between the agency and the generic\n\t\t\t\tnew animal drug sponsor.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idfe37190931f943e8986405691c20be94", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Review of advertising and labeling prior to\n\t\t\t\tapproval of an abbreviated application or supplemental abbreviated application,\n\t\t\t\tbut not after such application has been approved.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(H)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id682dd24a3be843ecb77a23b85545731f", "@commented": "no"}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": [{"#tail": " and ", "#text": "supplemental abbreviated application for a generic new animal\n\t\t\t\tdrug"}, {"#tail": " mean a\n\t\t\t\trequest to the Secretary to approve a change in an approved abbreviated\n\t\t\t\tapplication.", "#text": "supplemental abbreviated application"}], "#text": "The\n\t\t\t\tterms ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(11)"}, "header": {"#tail": "\n                ", "#text": "Supplemental abbreviated application for\n\t\t\t\tgeneric new animal drug", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id3415d393a8314ab99d600513ca224815", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idBA43A3FF5D0B4A07A6EBEDE134DBD544", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "idCE203E7223C9448BA10C1238E884DF6F", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id317629433EE749E59AA433810759A5AE"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id105B4517DF0E45CC895D417541929E33", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 742 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:742"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/379j-22", "#text": "21 U.S.C. 379j\u201322", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "203."}, "header": {"#tail": "\n        ", "#text": "Reauthorization; reporting\n\t\t\t requirements", "@display-inline": "yes-display-inline"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"@section-type": "subsequent-section", "#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "742."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reauthorization; reporting\n\t\t\t\trequirements", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report concerning the\n\t\t\t\tprogress of the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " in achieving the goals identified\n\t\t\t\tin the letters described in ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " toward expediting the generic new animal drug development\n\t\t\t\tprocess and the review of abbreviated applications for generic new animal\n\t\t\t\tdrugs, supplemental abbreviated applications for generic new animal drugs, and\n\t\t\t\tinvestigational submissions for generic new animal drugs during such fiscal\n\t\t\t\tyear.", "@entity-type": "act", "#text": "section 201(b) of the Animal Generic Drug User Fee\n\t\t\t\tAmendments of 2013", "@value": "Animal Generic Drug User Fee Amendments of 2013/s:201/ss:b", "@proposed": "true"}], "#text": "Beginning with fiscal year 2014, not later\n\t\t\t\tthan 120 days after the end of each fiscal year during which fees are collected\n\t\t\t\tunder this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Performance reports", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idcc2b5fe0841b4a58a399eacfdda009d9", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report on the implementation of the\n\t\t\t\tauthority for such fees during such fiscal year and the use, by the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", of the fees collected during such fiscal year for which\n\t\t\t\tthe report is made.", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later\n\t\t\t\tthan 120 days after the end of each fiscal year during which fees are collected\n\t\t\t\tunder this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fiscal report", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id835ab04b07944f3495a0b776958364cf", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the reports\n\t\t\t\trequired under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:a", "@proposed": "true"}, {"#tail": " available to the public on the Internet\n\t\t\t\tWeb site of the Food and Drug Administration.", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:b", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Public availability", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "ide8a865f3fe1b4ddcb4bce882749273bc", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reauthorization", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to the goals,\n\t\t\t\tand plans for meeting the goals, for the process for the review of abbreviated\n\t\t\t\tapplications for generic new animal drugs for the first 5 fiscal years after\n\t\t\t\tfiscal year 2018, and for the reauthorization of this part for such fiscal\n\t\t\t\tyears, the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall consult with\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping recommendations to present to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Consultation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idac49410f3e04466eb5d4705b029658a1", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the\n\t\t\t\tHouse of Representatives", "@entity-id": "HIF00"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id4424ac037ce048e08c13f9ace54078f0", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor,\n\t\t\t\tand Pensions of the Senate", "@entity-id": "SSHR00"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id3c0b326cc82b4f2eb486d437381d908d", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "scientific and academic experts;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id2007e9060e7f4ce0b9906b7dc174a91e", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "veterinary professionals;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idcbae80e7d0434ac3bb6fc50b2419692b", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "representatives of patient and consumer\n\t\t\t\tadvocacy groups; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id8a94fc1d5b374adaafd894f8aea8ad47", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the regulated industry.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ida454eb7bb12e4255b1ef5fabeb9e6b84", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to beginning negotiations with the\n\t\t\t\tregulated industry on the reauthorization of this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prior public input", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "id915ae04fbce44fa68d50558bc13be3a5", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice in the Federal Register\n\t\t\t\trequesting public input on the reauthorization;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "iddd34e804fc044010a55d22cf279343bb", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:a", "@proposed": "true"}, "#text": "hold a public meeting at which the public\n\t\t\t\tmay present its views on the reauthorization, including specific suggestions\n\t\t\t\tfor changes to the goals referred to in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "idbdd37c4c28c545cc92470a1b8f5b60ac", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period of 30 days after the\n\t\t\t\tpublic meeting to obtain written comments from the public suggesting changes to\n\t\t\t\tthis part; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id8023f630ea3b43e5b7f94f0391a2c307", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish the comments on the Food and Drug\n\t\t\t\tAdministration\u2019s Internet Web site.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id63c29888c82f4caca110a4dc9f89ad35", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\thold discussions with representatives of veterinary, patient, and consumer\n\t\t\t\tadvocacy groups to continue discussions of their views on the reauthorization\n\t\t\t\tand their suggestions for changes to this part as expressed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:2", "@proposed": "true"}], "#text": "Not less frequently than once every 4\n\t\t\t\tmonths during negotiations with the regulated industry, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Periodic consultation", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idd320528a5f7645c38d661673a6a963e9", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "After\n\t\t\t\tnegotiations with the regulated industry, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Public review of\n\t\t\t\trecommendations", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "idb6e5f2fa49e94ca7bcaf49911e87812b", "@commented": "no", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the congressional committees specified in such\n\t\t\t\tparagraph;", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:1", "@proposed": "true"}, "#text": "present the recommendations developed under\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id3e2b89a584794471bca05fa2ffd5c086", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such recommendations in the Federal\n\t\t\t\tRegister;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ida0a1729c8cc34b9dae0c2eaf1094eb5f", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for a period of 30 days for the\n\t\t\t\tpublic to provide written comments on such recommendations;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id8cc0c572ab4d40babe8735eb35f0d0f8", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a meeting at which the public may\n\t\t\t\tpresent its views on such recommendations; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id94f16dea6f284626a20cfc70792d3aa4", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "after consideration of such public views\n\t\t\t\tand comments, revise such recommendations as necessary.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ida0afecd1e23a4b2492d2c63e3af311e0", "@commented": "no"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall transmit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the revised\n\t\t\t\trecommendations under ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", a summary of the views and comments\n\t\t\t\treceived under such paragraph, and any changes made to the recommendations in\n\t\t\t\tresponse to such views and comments.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:4", "@proposed": "true"}], "#text": "Not later\n\t\t\t\tthan January 15, 2018, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Transmittal of\n\t\t\t\trecommendations", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "ide67e693bd59046f0bba725622f01a5e0", "@commented": "no"}, {"#tail": "\n            ", "@id": "idb6c9d4b8ddaf488fbdc61d48bc0fc4f0", "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Minutes of negotiation meetings", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to ", "@entity-type": "act", "#text": "paragraphs (1) through (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:1..5", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall\n\t\t\t\tmake publicly available, on the Internet Web site of the Food and Drug\n\t\t\t\tAdministration, minutes of all negotiation meetings conducted under this\n\t\t\t\tsubsection between the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the regulated\n\t\t\t\tindustry.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Before presenting the recommendations\n\t\t\t\tdeveloped under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Public availability", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "id8da31d49fa5d4e03acf0fc6e923ea800", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall summarize any substantive proposal made by any party to the\n\t\t\t\tnegotiations as well as significant controversies or differences of opinion\n\t\t\t\tduring the negotiations and their\n\t\t\t\tresolution.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:6/sp:A", "@proposed": "true"}, "#text": "The minutes described under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Content", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "ide3d516771ddb4edb9694aa02f70d8dfd", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "idfc6a959f0e7c4f0e9ae966273a14cbfa", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id64016AE763B143F8BB332EDA9D3D69A0", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id007B6113BEBB47D8BCF3460EDCDFD939"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id86BF1F833AFE43B28EDEE90F35A3DA96", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as in effect on the day before the date\n\t\t\t of enactment of this title, shall continue to be in effect with respect to\n\t\t\t abbreviated applications for a generic new animal drug and supplemental\n\t\t\t abbreviated applications for a generic new animal drug (as defined in such part\n\t\t\t as of such day) that on or after October 1, 2008, but before October 1, 2013,\n\t\t\t were accepted by the ", "@entity-type": "act", "#text": "part 5 of subchapter C of chapter VII of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:5"}, {"#tail": " for filing with respect to\n\t\t\t assessing and collecting any fee required by such part for a fiscal year prior\n\t\t\t to fiscal year 2014.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Notwithstanding the\n\t\t\t amendments made by this title, ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "204."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idE3F39FD53D1C45CCAF4D42AE9FAB3054", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", as amended by this\n\t\t\t title, shall be assessed for all abbreviated applications for a generic new\n\t\t\t animal drug and supplemental abbreviated applications for a generic new animal\n\t\t\t drug received on or after October 1, 2013, regardless of the date of enactment\n\t\t\t of this Act.", "@entity-type": "act", "#text": "part 5 of subchapter C of\n\t\t\t chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:5"}, "#text": "The amendments made by\n\t\t\t this title shall take effect on October 1, 2013, or the date of enactment of\n\t\t\t this Act, whichever is later, except that fees under ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "205."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id0093861360504679B096AF5D36435FAA", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "206."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Sunset dates", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease\n\t\t\t to be effective October 1, 2018.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 741 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:741", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201321", "@value": "usc/21/379j\u201321", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-21", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Authorization", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id7d12783b3b50456b9bcaeb4239a18160", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease to be effective January 31, 2019.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 742 of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:742", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201322", "@value": "usc/21/379j\u201322", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-22", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Reporting requirements", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "ide4387464b55c450689665d11bd28c6a9", "@commented": "no"}, {"#tail": "\n      ", "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Previous sunset provision", "@display-inline": "yes-display-inline"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 204 of the Animal Generic Drug User Fee Act of\n\t\t\t 2008", "@value": "Animal Generic Drug User Fee Act of 2008/s:204"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "pl/110/316", "#text": "Public Law 110\u2013316", "@legal-doc": "public-law"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In general", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id560945a3ba304afcbfb7e9fb3fe3f851", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", by striking the\n\t\t\t item relating to ", "@entity-type": "act", "#text": "section 1", "@value": "Animal Generic Drug User Fee Act of 2008/s:1"}, {"#tail": ".", "@entity-type": "act", "#text": "section 204", "@value": "Animal Generic Drug User Fee Act of 2008/s:204"}], "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended in the table of contents in ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Animal Generic Drug User Fee Act of 2008", "@value": "Animal Generic Drug User Fee Act of 2008"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public\n\t\t\t Law 110\u2013316", "@value": "public-law/110/316"}], "@entity-type": "law-citation", "#text": "\n              "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Conforming amendment", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "idb437a3f3cd77458aaa8b9fdd29c5c6a7", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id118d05bc7b3c4d39aef1e2668cd6cbbc", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id6738992BAF6E4409B631A215FF4D8E5C", "@commented": "no"}], "enum": {"#tail": "\n      ", "#text": "II"}, "#tail": "\n  ", "header": {"#tail": "\n\t\t\t", "#text": "Fees relating to generic animal\n\t\t\t drugs", "@display-inline": "yes-display-inline"}, "#text": "\n      ", "@id": "id887345CBA94A46EFAF59D050D74EF0E8", "@commented": "no"}], "#tail": "\n\t", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Animal Drug and Animal Generic Drug\n\t\t\t User Fee Reauthorization Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "S1", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Table of contents; references in\n\t\t\t Act", "@display-inline": "yes-display-inline"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The table of contents of this Act is as\n\t\t\t follows:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Table of contents", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "toc": {"#tail": "\n\t\t\t", "#text": "\n\t\t\t\t\t", "toc-entry": [{"@idref": "S1", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 1. Short\n\t\t\t\ttitle."}, {"@idref": "id6DDE233C8DD34BA49B288F3202F70B43", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 2. Table of contents; references in Act."}, {"@idref": "idCAB9CAD96B1741ABBCE4EB6FD7B2A456", "@level": "title", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "TITLE I\u2014Fees relating to animal drugs"}, {"@idref": "idF24B38947FC6403FAF022C0E445C8BB9", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 101. Short title; finding."}, {"@idref": "id18C46899033642ECAD36671387E81948", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 102. Definitions."}, {"@idref": "idE57FA6A8996142F597DE8AD3F7810778", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 103. Authority to assess and use animal drug\n\t\t\t\tfees."}, {"@idref": "idF95379A251544E6E81CF9BBCFDFA1C6E", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 104. Reauthorization; reporting requirements."}, {"@idref": "idba28b0f6449e4cf594c392846a403b7d", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 105. Savings clause."}, {"@idref": "idc9d1267aec5c4c19b7d4aa9c166e8eee", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 106. Effective date."}, {"@idref": "id0b82b2aad4a449f1a2d259581c5c328c", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 107. Sunset dates."}, {"@idref": "id887345CBA94A46EFAF59D050D74EF0E8", "@level": "title", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "TITLE II\u2014Fees relating to generic animal drugs"}, {"@idref": "id7BD7ADAD8E32489AACA44A75A67EB6D3", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 201. Short title; finding."}, {"@idref": "id105B4517DF0E45CC895D417541929E33", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 202. Authority to assess and use generic new animal drug\n\t\t\t\tfees."}, {"@idref": "id86BF1F833AFE43B28EDEE90F35A3DA96", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 203. Reauthorization; reporting requirements."}, {"@idref": "idE3F39FD53D1C45CCAF4D42AE9FAB3054", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 204. Savings clause."}, {"@idref": "id0093861360504679B096AF5D36435FAA", "@level": "section", "#tail": "\n\t\t\t\t\t", "@bold": "off", "#text": "Sec. 205. Effective date."}, {"@idref": "id6738992BAF6E4409B631A215FF4D8E5C", "@level": "section", "#tail": "\n\t\t\t\t", "@bold": "off", "#text": "Sec. 206. Sunset dates."}]}, "#text": "\n        ", "@id": "id6563FD38C07040FEB98F43E38C40CD71", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Except as otherwise specified, amendments\n\t\t\t made by this Act to a section or other provision of law are amendments to such\n\t\t\t section or other provision of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 301 et seq.", "@value": "usc/21/301/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "References in Act", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idE29AD33021E4498E9F8AC1985ECF307F", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "id6DDE233C8DD34BA49B288F3202F70B43", "@commented": "no"}], "@display-enacting-clause": "yes-display-enacting-clause", "#text": "\n\t\t"}, "@public-print": "no", "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S622 ES: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}